🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Avinger Inc faces Nasdaq delisting over share price

EditorLina Guerrero
Published 11/22/2024, 04:44 PM
AVGR
-

Avinger Inc (NASDAQ:AVGR), a medical device company, has received a notification from the Nasdaq Stock Market indicating non-compliance with the exchange's minimum bid price requirement. On November 20, 2024, the company was informed that its common stock had not met the minimum $1 bid price for 32 consecutive business days, as stipulated by Nasdaq Listing Rule 5550(a)(2).

The company, which is listed on the Nasdaq Capital Market under the ticker symbol AVGR, now has a 180-day period, until May 19, 2025, to regain compliance. To achieve this, Avinger's common stock must maintain a closing bid price of at least $1 for a minimum of ten consecutive business days within this timeframe.

Currently, the notice from Nasdaq does not affect the trading of Avinger's securities on the market. However, if the company fails to meet the required bid price by the end of the 180-day grace period, it may be granted an additional 180 days to comply. This extension is contingent on the company meeting all other initial listing standards, except for the bid price requirement, and on providing written notice of its intent to remedy the deficiency, potentially through a reverse stock split.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.